Related Experiment Video

Updated: Jun 24, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

259

Comprehensive identification and potential application of genetic alteration-driven enhancer RNAs for eRNA-targeted

Hongying Zhao1, Caiyu Zhang1,2,3, Lin Bo1

  • 1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang 150081, China.

Genes & Diseases
|June 13, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
11:52

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

10.4K
Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
10:46

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Published on: June 2, 2018

9.3K

Related Experiment Videos

Last Updated: Jun 24, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

259
Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
11:52

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

10.4K
Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
10:46

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Published on: June 2, 2018

9.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

Articles linked to this work by shared authors, journal, and citation graph.

Self-reconstruction of single copper atoms drives precise hydroxyl radicals generation for efficient water disinfection.

Nature communications·2026

Reversing zinc dyshomeostasis and oxidative stress: A metallothionein 1-activating MXene/Zn2+ triple-action nanotherapeutic strategy for chronic non-bacterial prostatitis.

Bioactive materials·2026

Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial.

Circulation·2026

Paired Electrocatalytic Valorization of Phenolic Pollutants Into p-Benzoquinone and p-Aminophenol.

Angewandte Chemie (International ed. in English)·2026

Blood acylcarnitine profile alterations and fatty acid metabolism dysregulation associated with severe retinopathy of prematurity in preterm infants.

Frontiers in medicine·2026

Reconstructing lattice Cu2+ to surface Cu0 in CuCo spinel drives reverse charge transfer for selective peracetic acid activation toward water decontamination.

Journal of hazardous materials·2026

Steatotic liver-derived extracellular vesicles deliver ACSL4 to potentiate hepatic ischemia-reperfusion injury by orchestrating a ferroptosis-mitochondrial apoptosis cascade.

Genes & diseases·2026

LAMA5 pathogenic variant uncovers a novel autoantigen in membranous nephropathy.

Genes & diseases·2026

PINK1 deficiency exacerbates age-related bone loss in association with enhanced inflammatory adipocyte differentiation.

Genes & diseases·2026

Single-cell sequencing-guided discovery of narciclasine as a dual VCAM-1/ICAM-1 inhibitor for atherosclerosis management.

Genes & diseases·2026

Autosomal dominant gain-of-function mutations in LCP1 cause a syndromic neutropenia and immunodeficiency.

Genes & diseases·2026

High-throughput chemical screen identifies epothilone B in modulating inflammatory bowel disease by triggering neutrophil apoptosis.

Genes & diseases·2026

Rebuilding a protective allele with ADAR site-directed RNA editing.

Molecular therapy. Nucleic acids·2026

Proximal Neck Diameter Changes Following Zone 0 TEVAR With or Without Ascending Aortic Wrapping.

Annals of vascular surgery·2026

Evaluating a biochemical TB medication adherence test: Insights from image-based reporting through a patient companion app.

PLOS global public health·2026

Mechanical Ventilation Practices in Traumatic Brain Injury: A Systematic Review of Contemporary Evidence.

Cureus·2026

Decision-centered wearable biosensors for personalized rehabilitation: integrating multimodal monitoring, artificial intelligence, and closed-loop intervention.

Frontiers in bioengineering and biotechnology·2026

Vascular-device suit concordance: a tri-ecological framework for eco-rebalancing.

Trends in molecular medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us